https://xintela.se/mfn_news/ 2026-05-12T19:03:36+00:00 https://xintela.se/en/mfn_news/xintela-publication-on-eqstem-treatment-of-horses-in-a-preclinical-osteoarthritis-study-awarded-best-basic-science-paper/ 2026-05-12T19:03:36+00:00 https://xintela.se/mfn_news/xintelas-publikation-om-eqstem-behandling-av-hastar-i-en-preklinisk-artrosstudie-har-utsetts-till-basta-grundvetenskapliga-artikel/ 2026-05-12T19:03:36+00:00 https://xintela.se/mfn_news/xintela-beviljat-amerikanskt-patent-for-xstem-behandling-av-svarlakta-sar-och-huddefekter/ 2026-05-12T19:03:36+00:00 https://xintela.se/en/mfn_news/xintela-granted-us-patent-for-xstem-treatment-of-difficult-to-heal-wounds-and-skin-defects/ 2026-05-12T19:03:36+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela-ab-publ-8/ 2026-05-12T19:03:36+00:00 https://xintela.se/mfn_news/xintela-ab-publicerar-arsredovisning-for-2025/ 2026-05-12T19:03:36+00:00 https://xintela.se/en/mfn_news/xintela-ab-publishes-annual-report-2025/ 2026-05-12T19:03:36+00:00 https://xintela.se/mfn_news/forslag-avseende-styrelseledamoter-m-m-infor-xintelas-arsstamma/ 2026-05-12T19:03:36+00:00 https://xintela.se/en/mfn_news/xintela-granted-patent-in-japan-for-xstem-treatment-of-acute-respiratory-distress-syndrome-ards/ 2026-05-12T19:03:36+00:00 https://xintela.se/mfn_news/xintela-beviljat-patent-i-japan-for-xstem-behandling-av-acute-respiratory-distress-syndrome-ards/ 2026-05-12T19:03:36+00:00 https://xintela.se/mfn_news/nytt-nummer-av-xintelling-nr-2-2024/ 2026-05-07T12:52:07+00:00 https://xintela.se/en/mfn_news/new-issue-of-xintelling-no-2-2024/ 2026-05-07T12:52:01+00:00 https://xintela.se/mfn_news/nytt-nummer-av-xintelling-nr-3-2024/ 2026-05-07T12:51:48+00:00 https://xintela.se/en/mfn_news/new-issue-of-xintelling-no-3-2024/ 2026-05-07T12:51:41+00:00 https://xintela.se/mfn_news/nytt-nummer-av-xintelling-nr-4-2024/ 2026-05-07T12:51:33+00:00 https://xintela.se/en/mfn_news/new-issue-of-xintelling-no-4-2024/ 2026-05-07T12:51:27+00:00 https://xintela.se/en/mfn_news/new-issue-of-xintelling-no-5-2024/ 2026-05-07T12:51:16+00:00 https://xintela.se/mfn_news/nytt-nummer-av-xintelling-nr-5-2024/ 2026-05-07T12:51:05+00:00 https://xintela.se/en/mfn_news/new-issue-of-xintelling-no-6-2025/ 2026-05-07T12:44:49+00:00 https://xintela.se/mfn_news/nytt-nummer-av-xintelling-nr-6-2025/ 2026-05-07T12:44:43+00:00 https://xintela.se/en/mfn_news/new-issue-of-xintelling-no-2-2025/ 2026-05-07T12:43:40+00:00 https://xintela.se/mfn_news/nytt-nummer-av-xintelling-nr-2-2025/ 2026-05-07T12:43:33+00:00 https://xintela.se/mfn_news/nytt-nummer-av-xintelling-nr-1-2026/ 2026-05-07T12:42:26+00:00 https://xintela.se/en/mfn_news/new-issue-of-xintelling-no-1-2026/ 2026-05-07T12:41:39+00:00 https://xintela.se/mfn_news/xintela-beslutar-om-emission-av-teckningsoptioner-till-fenja-capital-inom-ramen-for-inganget-laneavtal/ 2026-03-31T09:41:15+00:00 https://xintela.se/en/mfn_news/xintela-completes-clinical-study-with-xstem-in-difficult-to-heal-leg-ulcers/ 2026-03-31T09:41:15+00:00 https://xintela.se/mfn_news/xintela-offentliggor-utfall-i-foretradesemissionen-2/ 2026-03-31T09:41:15+00:00 https://xintela.se/mfn_news/xintela-slutfor-klinisk-studie-med-xstem-pa-svarlakta-bensar/ 2026-03-31T09:41:15+00:00 https://xintela.se/en/mfn_news/xintela-ab-year-end-report-2025/ 2026-03-31T09:41:15+00:00 https://xintela.se/mfn_news/xintela-ab-bokslutskommunike-2025/ 2026-03-31T09:41:15+00:00 https://xintela.se/mfn_news/xintela-offentliggor-informationsdokument-avseende-foretradesemission/ 2026-03-31T09:41:15+00:00 https://xintela.se/mfn_news/xintela-genomfor-foretradesemission-av-aktier-om-cirka-728-msek-och-upptar-lan-om-20-msek/ 2026-03-31T09:41:15+00:00 https://xintela.se/mfn_news/sista-patienten-doserad-i-xintelas-kliniska-studie-pa-svarlakta-bensar/ 2026-01-26T22:51:06+00:00 https://xintela.se/en/mfn_news/xintela-ab-interim-report-january-september-2025/ 2026-01-26T22:51:06+00:00 https://xintela.se/mfn_news/xintela-ab-delarsrapport-januari-september-2025/ 2026-01-26T22:51:06+00:00 https://xintela.se/en/mfn_news/last-patient-dosed-in-xintelas-clinical-study-on-difficult-to-heal-leg-ulcers/ 2026-01-26T22:51:06+00:00 https://xintela.se/mfn_news/xintela-flyttar-fram-bolagets-arsstamma-till-den-30-maj-2016/ 2025-11-20T16:32:23+00:00 https://xintela.se/mfn_news/forsta-handelsdag-for-xintela-pa-nasdaq-first-north-den-22-mars-2016/ 2025-11-20T16:32:23+00:00 https://xintela.se/mfn_news/xintelas-nyemission-overtecknad/ 2025-11-20T16:32:23+00:00 https://xintela.se/mfn_news/xintela-inleder-teckningsperiod-for-nyemission-om-30-msek-infor-notering-pa-first-north/ 2025-11-20T16:32:23+00:00 https://xintela.se/mfn_news/xintela-offentliggor-prospekt-avseende-nyemission-av-units-infor-planerad-notering-pa-nasdaq-first-north/ 2025-11-20T16:32:23+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela-3/ 2025-11-20T16:32:22+00:00 https://xintela.se/mfn_news/xintela-offentliggor-arsredovisning-for-2015/ 2025-11-20T16:32:22+00:00 https://xintela.se/mfn_news/xintela-inleder-studie-for-behandling-av-ledbroskskador-pa-hastar-i-usa/ 2025-11-20T16:32:22+00:00 https://xintela.se/en/mfn_news/xintela-initiates-a-study-on-the-treatment-of-cartilage-damage-in-horses-in-the-usa/ 2025-11-20T16:32:22+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-2-2016/ 2025-11-20T16:32:22+00:00 https://xintela.se/mfn_news/xintela-kontrakterar-professor-christer-betsholtz-som-vetenskaplig-och-strategisk-radgivare/ 2025-11-20T16:32:22+00:00 https://xintela.se/en/mfn_news/xintela-engages-professor-christer-betsholtz-as-scientific-an-strategic-advisor/ 2025-11-20T16:32:22+00:00 https://xintela.se/mfn_news/xintela-forstarker-organisationen-med-caroline-ehrencrona-som-director-clinical-development-and-regulatory-affairs/ 2025-11-20T16:32:22+00:00 https://xintela.se/en/mfn_news/xintela-strengthens-its-organisation-with-the-appointment-of-caroline-ehrencrona-as-director-clinical-development-and-regulatory-affairs/ 2025-11-20T16:32:22+00:00 https://xintela.se/mfn_news/kommunike-fran-xintelas-arsstamma-2016/ 2025-11-20T16:32:22+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-1-2016/ 2025-11-20T16:32:22+00:00 https://xintela.se/mfn_news/beslutsforslag-infor-xintelas-arsstamma-30-maj-2016/ 2025-11-20T16:32:22+00:00 https://xintela.se/en/mfn_news/xintela-recruits-rickard-mosell-as-head-of-business-development/ 2025-11-20T16:32:21+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-3-2016/ 2025-11-20T16:32:21+00:00 https://xintela.se/mfn_news/halvarsrapport-2016-01-01-till-2016-06-30/ 2025-11-20T16:32:21+00:00 https://xintela.se/en/mfn_news/xintela-receives-15-msek-in-dispute-settlement/ 2025-11-20T16:32:21+00:00 https://xintela.se/mfn_news/xintela-erhaller-15-msek-genom-forlikning-i-tvist/ 2025-11-20T16:32:21+00:00 https://xintela.se/en/mfn_news/newsletter-no-1/ 2025-11-20T16:32:21+00:00 https://xintela.se/en/mfn_news/newsletter-no-2-2016/ 2025-11-20T16:32:21+00:00 https://xintela.se/mfn_news/forskningscentrum-for-cell-och-genterapi/ 2025-11-20T16:32:21+00:00 https://xintela.se/en/mfn_news/xintelas-stem-cells-show-positive-treatment-effects-on-cartilage-damage-in-horse-study/ 2025-11-20T16:32:20+00:00 https://xintela.se/en/mfn_news/newsletter-december/ 2025-11-20T16:32:20+00:00 https://xintela.se/mfn_news/xintela-uppvisar-positiva-resultat-i-genomford-haststudie/ 2025-11-20T16:32:20+00:00 https://xintela.se/en/mfn_news/xintela-reports-positive-results-from-completed-horse-study/ 2025-11-20T16:32:20+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-6-2016/ 2025-11-20T16:32:20+00:00 https://xintela.se/en/mfn_news/xintelas-focus-in-the-cancer-arena/ 2025-11-20T16:32:20+00:00 https://xintela.se/mfn_news/delarsrapport-2016-01-01-till-2016-09-30/ 2025-11-20T16:32:20+00:00 https://xintela.se/mfn_news/xintela-tidigarelagger-datum-for-publicering-av-bokslutskommunike/ 2025-11-20T16:32:20+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-5-2016/ 2025-11-20T16:32:20+00:00 https://xintela.se/mfn_news/xintela-byter-certified-adviser-till-erik-penser-bank/ 2025-11-20T16:32:20+00:00 https://xintela.se/en/mfn_news/focus-on-commercial-development/ 2025-11-20T16:32:20+00:00 https://xintela.se/en/mfn_news/preparing-for-an-exciting-autumn/ 2025-11-20T16:32:20+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-4-2016/ 2025-11-20T16:32:20+00:00 https://xintela.se/mfn_news/xintela-anstaller-rickard-mosell-som-head-of-business-development/ 2025-11-20T16:32:20+00:00 https://xintela.se/en/mfn_news/xintela-reports-positive-preclinical-results-in-cancer-project/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/xintelas-stamceller-visar-positiva-behandlingseffekter-pa-broskskada-i-haststudie/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela-2/ 2025-11-20T16:32:19+00:00 https://xintela.se/en/mfn_news/newsletter-no-2-2017/ 2025-11-20T16:32:19+00:00 https://xintela.se/en/mfn_news/xintela-strengthens-business-development-and-reorganizes/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/xintela-forstarker-affarsutveckling-och-omorganiserar/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-2-2017/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/bokslutskommunike-2016-01-01-till-2016-12-31/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/xintela-tillfors-cirka-10-msek-genom-nyttjande-av-teckningsoptioner-av-serie-to1/ 2025-11-20T16:32:19+00:00 https://xintela.se/en/mfn_news/newsletter-no-1-2017/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/insynspersoner-och-huvudagare-avser-nyttja-teckningsoptioner-av-serie-to-1/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-1-2017/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/idag-inleds-teckningsperioden-for-teckningsoptioner-av-serie-to1/ 2025-11-20T16:32:19+00:00 https://xintela.se/mfn_news/xintela-rapporterar-positiva-prekliniska-resultat-i-cancerprojekt/ 2025-11-20T16:32:19+00:00 https://xintela.se/en/mfn_news/keld-sondergaard-nominated-as-new-board-member/ 2025-11-20T16:32:18+00:00 https://xintela.se/mfn_news/keld-sondergaard-foreslas-som-ny-styrelseledamot/ 2025-11-20T16:32:18+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-3-2017/ 2025-11-20T16:32:18+00:00 https://xintela.se/mfn_news/xintela-offentliggor-arsredovisning-for-2016/ 2025-11-20T16:32:18+00:00 https://xintela.se/en/mfn_news/xintela-participates-in-multi-million-government-funded-initiative-to-form-a-cell-and-gene-therapy-research-center/ 2025-11-20T16:32:18+00:00 https://xintela.se/mfn_news/xintela-ar-partner-i-statlig-mangmiljonsatsning-pa-forskningscentrum-for-cell-och-genterapi/ 2025-11-20T16:32:18+00:00 https://xintela.se/mfn_news/xintela-tecknar-samforstandsavtal-med-co-don/ 2025-11-20T16:32:18+00:00 https://xintela.se/en/mfn_news/xintela-signs-memorandum-of-understanding-with-co-don/ 2025-11-20T16:32:18+00:00 https://xintela.se/mfn_news/kommunike-fran-xintelas-arsstamma-2017/ 2025-11-20T16:32:18+00:00 https://xintela.se/mfn_news/delarsrapport-2017-01-01-till-2017-03-31/ 2025-11-20T16:32:18+00:00 https://xintela.se/en/mfn_news/newsletter-no-3-2017/ 2025-11-20T16:32:18+00:00 https://xintela.se/en/mfn_news/newsletter-no-5-2017/ 2025-11-20T16:32:17+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-5-2017/ 2025-11-20T16:32:17+00:00 https://xintela.se/en/mfn_news/xintela-building-own-gmp-facility-for-stem-cell-production/ 2025-11-20T16:32:17+00:00 https://xintela.se/mfn_news/xintela-uppfor-egen-gmp-anlaggning-for-produktion-av-stamceller/ 2025-11-20T16:32:17+00:00 https://xintela.se/mfn_news/halvarsrapport-2017-01-01-till-2017-06-30/ 2025-11-20T16:32:17+00:00 https://xintela.se/en/mfn_news/newsletter-no-4-2017/ 2025-11-20T16:32:17+00:00 https://xintela.se/en/mfn_news/xintela-recruits-liselotte-theorell-as-director-product-development-and-quality-management/ 2025-11-20T16:32:17+00:00 https://xintela.se/mfn_news/xintela-rekryterar-liselotte-theorell-som-ansvarig-for-produktutveckling-och-kvalitetsledning/ 2025-11-20T16:32:17+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-4-2017/ 2025-11-20T16:32:17+00:00 https://xintela.se/en/mfn_news/keld-sondergaard-leaves-xintelas-board-of-directors/ 2025-11-20T16:32:17+00:00 https://xintela.se/mfn_news/keld-sondergaard-lamnar-xintelas-styrelse/ 2025-11-20T16:32:17+00:00 https://xintela.se/en/mfn_news/xintela-licenses-human-antibody-technology-for-cancer-therapy/ 2025-11-20T16:32:16+00:00 https://xintela.se/mfn_news/xintela-licensierar-antikroppsteknologi-for-utveckling-av-cancerterapi/ 2025-11-20T16:32:16+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-6-2017/ 2025-11-20T16:32:16+00:00 https://xintela.se/mfn_news/xintela-inleder-samarbete-med-det-japanska-bolaget-cellseed/ 2025-11-20T16:32:16+00:00 https://xintela.se/en/mfn_news/xintela-to-collaborate-with-japanese-cellseed-inc/ 2025-11-20T16:32:16+00:00 https://xintela.se/mfn_news/xintela-tillfors-cirka-500-ksek-efter-inlosen-av-teckningsoptioner/ 2025-11-20T16:32:16+00:00 https://xintela.se/mfn_news/delarsrapport-2017-01-01-till-2017-09-30/ 2025-11-20T16:32:16+00:00 https://xintela.se/en/mfn_news/xintela-interim-report-q3-2017/ 2025-11-20T16:32:16+00:00 https://xintela.se/en/mfn_news/xintela-raises-17-million-sek-in-debt-and-equity/ 2025-11-20T16:32:16+00:00 https://xintela.se/mfn_news/xintela-starker-kassan-med-17-msek-genom-riktad-nyemission-och-lan/ 2025-11-20T16:32:16+00:00 https://xintela.se/mfn_news/bokslutskommunike-2017-01-01-till-2017-12-31/ 2025-11-20T16:32:15+00:00 https://xintela.se/en/mfn_news/year-end-report-2017/ 2025-11-20T16:32:15+00:00 https://xintela.se/en/mfn_news/1351/ 2025-11-20T16:32:15+00:00 https://xintela.se/en/mfn_news/newsletter-no-6-2017/ 2025-11-20T16:32:15+00:00 https://xintela.se/en/mfn_news/xintela-develops-unique-methods-in-stem-cell-therapy-for-the-brain-and-broadens-patent-portfolio/ 2025-11-20T16:32:15+00:00 https://xintela.se/mfn_news/xintela-utvecklar-unika-metoder-for-stamcellsbehandling-av-hjarnan-och-breddar-patentportfoljen/ 2025-11-20T16:32:15+00:00 https://xintela.se/en/mfn_news/newsletter-no-1-2018/ 2025-11-20T16:32:15+00:00 https://xintela.se/mfn_news/xintela-forbereder-avknoppning-av-onkologiverksamheten-till-separat-bolag/ 2025-11-20T16:32:15+00:00 https://xintela.se/en/mfn_news/xintela-prepares-for-oncology-spinout/ 2025-11-20T16:32:15+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-1-2018/ 2025-11-20T16:32:15+00:00 https://xintela.se/mfn_news/xintela-erhaller-mums-status-for-behandling-av-artros-hos-hastar/ 2025-11-20T16:32:14+00:00 https://xintela.se/en/mfn_news/xintela-receives-mums-status-for-the-treatment-of-osteoarthritis-in-horses/ 2025-11-20T16:32:14+00:00 https://xintela.se/mfn_news/xintela-beslutar-om-konvertibelt-lan-om-5-msek/ 2025-11-20T16:32:14+00:00 https://xintela.se/mfn_news/kommunike-fran-xintelas-arsstamma-2018/ 2025-11-20T16:32:14+00:00 https://xintela.se/mfn_news/delarsrapport-2018-01-01-till-2018-03-31/ 2025-11-20T16:32:14+00:00 https://xintela.se/en/mfn_news/xintela-interim-report-q1-2018/ 2025-11-20T16:32:14+00:00 https://xintela.se/mfn_news/xintela-offentliggor-arsredovisning-for-2017/ 2025-11-20T16:32:14+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela/ 2025-11-20T16:32:14+00:00 https://xintela.se/en/mfn_news/xintelas-gmp-facility-is-completed-and-being-prepared-for-production-and-clinical-trials/ 2025-11-20T16:32:14+00:00 https://xintela.se/mfn_news/xintelas-gmp-anlaggning-ar-fardigbyggd-och-forbereds-for-produktion-och-kliniska-studier/ 2025-11-20T16:32:14+00:00 https://xintela.se/en/mfn_news/xintela-to-spin-out-oncology-business/ 2025-11-20T16:32:13+00:00 https://xintela.se/en/mfn_news/xintela-interim-report-q2-2018/ 2025-11-20T16:32:13+00:00 https://xintela.se/en/mfn_news/significant-progress-in-xintela/ 2025-11-20T16:32:13+00:00 https://xintela.se/mfn_news/viktiga-framsteg-i-xintela/ 2025-11-20T16:32:13+00:00 https://xintela.se/mfn_news/xintela-utvidgar-patentskyddet-inom-degenerativa-ledsjukdomar/ 2025-11-20T16:32:13+00:00 https://xintela.se/en/mfn_news/xintela-extends-patent-protection-for-degenerative-joint-diseases/ 2025-11-20T16:32:13+00:00 https://xintela.se/en/mfn_news/newsletter-no-2-2018/ 2025-11-20T16:32:13+00:00 https://xintela.se/mfn_news/xintela-tecknar-letter-of-intent-med-co-don/ 2025-11-20T16:32:13+00:00 https://xintela.se/en/mfn_news/xintela-signs-letter-of-intent-with-co-don/ 2025-11-20T16:32:13+00:00 https://xintela.se/mfn_news/nyhetsbrev-nr-2-2018/ 2025-11-20T16:32:13+00:00 https://xintela.se/mfn_news/kallelse-till-extra-bolagsstamma-i-xintela-ab-publ-5/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/xintela-beslutar-om-foretradesemission-om-cirka-248-msek-villkorat-av-godkannande-vid-extra-bolagsstamma/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/delarsrapport-2018-01-01-till-2018-06-30/ 2025-11-20T16:32:12+00:00 https://xintela.se/en/mfn_news/sven-kili-takes-role-as-chief-medical-officer-in-xintela/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/sven-kili-tar-rollen-som-chief-medical-officer-i-xintela/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/xintela-knoppar-av-onkologiverksamheten/ 2025-11-20T16:32:12+00:00 https://xintela.se/en/mfn_news/xintela-and-catalent-to-co-develop-brain-cancer-therapy-2/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/kommunike-fran-xintela-abs-extra-bolagsstamma-15-oktober-2018/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/kallelse-till-extra-bolagsstamma-i-xintela-ab-publ-4/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/xintela-beslutar-om-riktad-nyemission-till-bauerfeind-ag-om-cirka-50-msek/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/xintela-avbryter-foretradesemission-och-avser-att-genomfora-en-riktad-emission-till-strategisk-investerare-om-minst-25-msek-till-emissionskursen-6-kr/ 2025-11-20T16:32:12+00:00 https://xintela.se/mfn_news/kommunike-fran-xintela-abs-extra-bolagsstamma-2018/ 2025-11-20T16:32:12+00:00 https://xintela.se/en/mfn_news/a-successful-year/ 2025-11-20T16:32:11+00:00 https://xintela.se/en/mfn_news/xintela-at-partnering-conferences/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/xintela-utvidgar-och-forlanger-patentskyddet-for-broskcellsprodukter-och-broskcellsmarkorer/ 2025-11-20T16:32:11+00:00 https://xintela.se/en/mfn_news/xintela-broadens-and-extends-patent-protection-for-chondrocyte-products-and-chondrocyte-markers/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/ett-framgangsrikt-ar/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/xintela-pa-partneringkonferenser/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/konvertering-av-konvertibler-i-xintela/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/delarsrapport-2018-01-01-till-2018-09-30/ 2025-11-20T16:32:11+00:00 https://xintela.se/en/mfn_news/xintela-interim-report-q3-2018/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/xintela-and-catalent-to-co-develop-brain-cancer-therapy/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/bokslutskommunike-2018/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/xintela-publicerar-nya-resultat-fran-stamcellsstudie/ 2025-11-20T16:32:11+00:00 https://xintela.se/en/mfn_news/xintela-publishes-results-from-stem-cell-study/ 2025-11-20T16:32:11+00:00 https://xintela.se/mfn_news/kommunike-fran-xintelas-arsstamma-2019/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/xintela-offentliggor-delarsrapport-for-forsta-kvartalet/ 2025-11-20T16:32:10+00:00 https://xintela.se/en/mfn_news/steady-progress-and-xintela-is-growing/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/xintela-offentliggor-arsredovisning-for-2018/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/xintela-publicerar-resultat-fran-glioblastomstudie/ 2025-11-20T16:32:10+00:00 https://xintela.se/en/mfn_news/xintela-publishes-results-from-glioblastoma-study/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/kallelse-till-arsstamma-i-xintela-ab-publ-7/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/peter-edman-foreslas-som-ny-styrelseledamot/ 2025-11-20T16:32:10+00:00 https://xintela.se/en/mfn_news/peter-edman-nominated-as-new-board-member/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/projekten-gar-framat-och-xintela-vaxer/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/xintela-utser-sven-kili-som-chief-operating-officer/ 2025-11-20T16:32:10+00:00 https://xintela.se/en/mfn_news/xintela-appoints-sven-kili-as-chief-operating-officer/ 2025-11-20T16:32:10+00:00 https://xintela.se/en/mfn_news/year-end-report-2018/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/nyhetsbrev-juli-2019/ 2025-11-20T16:32:10+00:00 https://xintela.se/mfn_news/xintela-publicerar-positiva-prekliniska-resultat-fran-haststudie/ 2025-11-20T16:32:09+00:00 https://xintela.se/en/mfn_news/newsletter-december-2019/ 2025-11-20T16:32:09+00:00 https://xintela.se/mfn_news/xintela-konverterar-lan-om-ca-8-msek-och-tar-in-nytt-lan-om-10-msek/ 2025-11-20T16:32:09+00:00 https://xintela.se/mfn_news/nyhetsbrev-december-2019/ 2025-11-20T16:32:09+00:00 https://xintela.se/mfn_news/positiva-prekliniska-resultat-i-xintelas-glioblastomprojekt/ 2025-11-20T16:32:09+00:00 https://xintela.se/en/mfn_news/positive-preclinical-results-in-xintelas-glioblastoma-project/ 2025-11-20T16:32:09+00:00 https://xintela.se/mfn_news/xintela-offentliggor-delarsrapport-for-tredje-kvartalet/ 2025-11-20T16:32:09+00:00 https://xintela.se/en/mfn_news/xintela-publishes-interim-report-for-the-third-quarter/ 2025-11-20T16:32:09+00:00 https://xintela.se/mfn_news/xintela-erhaller-lan-om-ca-8-msek/ 2025-11-20T16:32:09+00:00 https://xintela.se/mfn_news/xintela-offentliggor-delarsrapport-for-andra-kvartalet/ 2025-11-20T16:32:09+00:00